Typically, says Dr
Of note, prior to attempting intra-ventricular infusion of MT-II, we tried multiple different regimens of MT-II intra-peritoneal injections in the MIA mice
The most significant clinical data on retatrutide to date come from a Phase 2 randomised controlled trial published in the New England Journal of Medicine (2023), which evaluated the drug across multiple doses in adults with obesity
2025 May;46(5):422-436
Recent real-world data from a three-year analysis by Prime Therapeutics show that only 37% of people using GLP-1 drugs for obesity remain on them longer than one year, with adherence plunging to just 8% by year three
Co-treatment with mercury and NAC significantly reduced the expression of MPO (2.49-fold, Table 2), HIF1 (2.12-fold, Table 3), MMP2 (1.94-fold, Table 4), TIMP1 (1.92-fold, Table 5), TIMP2 (1.92-fold, Table 6), NOS (2.00-fold, Table 7), and FN1 genes (1.85-fold, Table 8), while increasing SOD expression (0.76-fold, Table 9) compared to rats treated with a continuous mercury exposure alone
